FDA's Pause of Johnson & Johnson COVID Vaccine Rollout Could Pay Off
Matthew Hatcher/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now. The choice about when to pause the administration of a COVID vaccine over rare events is hard. News of adverse reactions could raise hesitancy. But so could an appearance of complacency. People who think it's clear whether the government made the right call are overconfident. This is an opinion column. The thoughts expressed are those of the author. I'm not sure the Food and Drug Administration and t...
Source: businessinsider.com